An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab
Titel:
An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab
Auteur:
Kennedy, Adam D. Solga, Michael D. Schuman, Theodore A. Chi, Amos W. Lindorfer, Margaret A. Sutherland, William M. Foley, Patricia L. Taylor, Ronald P.